Research Article

Sodium Butyrate Attenuated Diabetes-Induced Intestinal Inflammation by Modulating Gut Microbiota

Figure 3

SB treatment was associated with reductions in intestinal inflammation in DM model mice. Upon experimental termination, levels of intestinal (a) TNF-α, (b) IL-1β, (c) IL-6, (d) IL-17, (e) IL-10, and (f) TGF-β were measured. n = 6/group; vs. control and ## vs. DM group.
(a)
(b)
(c)
(d)
(e)
(f)